We are designing a smoke-free future

Our aim is to decrease the impact smoking has on public health. This is why we are developing a portfolio of smoke-free products and are assessing their impact on individual and public health with rigorous scientific methods.

Read about the smoke-free approach

Our collaborative initiatives

We are committed to sharing our results as the assessment of our products advances. We have established a portfolio of programs to foster innovation and independent verification of our research results.

PMI Postdoctoral Fellowship Program

We foster innovation and scientific excellence with passionate teams of experts from a variety of scientific and technical disciplines.

Scientific Update

This issue of the Scientific Update describes our work in systems toxicology with far-reaching significance beyond tobacco research.

PMinnovate

Our Idea Submission Portal is available to everyone and each concept is assessed by a panel of subject matter experts.

Research and development

Our rigorous development and assessment program for smoke-free products is inspired by the pharmaceutical industry's practices for novel drugs. Our program is run in accordance with the FDA's draft guidance on Modified Risk Tobacco Products (2012).

The people behind the scenes

Over 400 scientists, engineers and technicians work on the development and assessment of our smoke-free products.

Our smoke-free products

How do they work?

Our findings

What have we learned so far?

Understanding our approach

From product development through toxicology to the clinic and real life

Our network

Get to know our network

Scientific library

Read our research papers, presentations, posters

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products (“RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.